Compare FOR & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOR | BLFS |
|---|---|---|
| Founded | 2005 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2007 | 2013 |
| Metric | FOR | BLFS |
|---|---|---|
| Price | $24.83 | $19.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $31.75 | ★ $32.00 |
| AVG Volume (30 Days) | 117.8K | ★ 427.5K |
| Earning Date | 04-21-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $1,662,400,000.00 | $96,214,000.00 |
| Revenue This Year | $0.52 | $19.20 |
| Revenue Next Year | $7.72 | $18.07 |
| P/E Ratio | $86.45 | ★ N/A |
| Revenue Growth | 10.14 | ★ 16.97 |
| 52 Week Low | $18.00 | $19.15 |
| 52 Week High | $30.74 | $29.57 |
| Indicator | FOR | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 28.75 | 34.06 |
| Support Level | $24.05 | N/A |
| Resistance Level | $26.00 | $25.95 |
| Average True Range (ATR) | 0.87 | 0.97 |
| MACD | -0.58 | -0.27 |
| Stochastic Oscillator | 1.47 | 7.22 |
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.